In 2023, semaglutide (the active ingredient in Wegovy & Ozempic) was added to updated PCOS treatment guidance due to its ability to address insulin resistance
GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure
Cody Stanford, the drugs are only effective if taken consistently, and people who pause the medication may gain some weight back
Which lab values does the article's table connect to joint outcomes
Collectively, we suppose GLP-1R-based agonists are promising therapeutics for MASLD and its complications, probably by improving systemic metabolic disorders
If youve spent any time scrolling through social media lately, youve likely seen the buzz surrounding GLP-1 medications